The defendants appealed against their convictions of placing on the market a medicinal product without holding an EC or UK marketing authorisation contrary to paragraph 1 of Schedule 3 to the 1994 Regulations. They said that they had not intended the sale of the products with the EEA.
Held: The appeals succeeded. The Regulations could not be read or intended to apply to sales to end users outside the EEA.
Lord Justice Hooper, Mr Justice Tomlinson and Mrs Justice Swift
 EWCA Crim 2311, Times 18-Nov-2009
Updated: 05 August 2022; Ref: scu.377890